Ever closer to a prophylactic vaccine for HCV. (2013)

First Author: Swadling L
Attributed to:  Immunity in the face of diversity and the development of novel potent HCV vaccines funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1517/14712598.2013.791277

PubMed Identifier: 23651228

Publication URI: http://europepmc.org/abstract/MED/23651228

Type: Journal Article/Review

Volume: 13

Parent Publication: Expert opinion on biological therapy

Issue: 8

ISSN: 1471-2598